Read Time 37 minutes

Inflammaging: The Silent Inflammation That Speeds Up Aging

Key takeaways

  • Inflammaging is a chronic, low-grade inflammation that accelerates aging and increases the risk of diseases such as heart disease, dementia, and osteoporosis.
  • Key contributors include senescent cells, gut dysbiosis, and poor lifestyle habits, making inflammation both measurable and modifiable.
  • You can slow inflammaging through anti-inflammatory habits, such as a Mediterranean-style diet, regular exercise, stress reduction, quality sleep, and targeted therapies.

Overview

Many people find themselves feeling older than their years. Stiff joints, unexplained fatigue, cognitive fog, and a growing susceptibility to illnesses are often written off as inevitable signs of aging. But what if aging isn’t the sole culprit? 

Scientific insights reveal that a silent process, known as inflammaging, could be accelerating the ticking of your biological clock. This low-grade, chronic inflammatory state is a key driver of age-related decline. From an evolutionary perspective, inflammaging may have developed as a trade-off, where immune system changes that once protected us in early life now contribute to chronic inflammation and aging in later years.

However, here is the good news: Understanding inflammaging empowers you to take proactive steps to slow this process and extend not only your lifespan but also your healthspan. This blog offers a deep examination of inflammaging, from its cellular mechanisms to actionable solutions, to help you age more gracefully and vibrantly.

What is inflammaging?

Inflammaging, a term coined by scientists over two decades ago, combines the concepts of “inflammation” and “aging.” It describes the persistent, low-grade inflammation that accompanies the aging process. Inflammaging is now recognized as a key feature of human aging, influencing biological mechanisms and contributing to the decline in health and increased risk of disease as individuals age. 

Unlike the acute inflammation that helps your body recover from injuries or infections, inflammaging is a slow-burning but systemic condition that can set the stage for numerous aging-associated diseases.

Inflammaging is characterized by systemic inflammation without an apparent external trigger. Fundamental to this process is the imbalance between pro-inflammatory and anti-inflammatory responses as we age. Chronic inflammation, once thought to be a side effect of aging, is now acknowledged as a key driver of biological aging.

Key inflammatory markers

Inflammaging is measurable through specific biomarkers:

  • C-reactive protein (CRP): A standard indicator of systemic inflammation.
  • Interleukin-6 (IL-6): It plays a role in inflammation and immune responses; its elevated levels are a hallmark of inflammaging.
  • Tumor necrosis factor-alpha (TNF-α): A cytokine linked to cellular damage and immune dysregulation.

Recent advances even allow scientists to use tools like the iAge inflammatory clock, which predicts biological age based on inflammatory markers.

How does inflammaging damage your body?

Over time, unmanaged inflammaging contributes to the gradual deterioration of tissues and organ systems, increasing the risk of disease or dysfunction. Here’s how it impacts key physiological domains:

Cardiovascular health and cardiovascular disease

Chronic inflammation accelerates processes like atherosclerosis, where arterial walls thicken due to plaque buildup. Endothelial dysfunction, which involves vascular endothelial cells, impairs the protective barrier of blood vessels, triggering inflammatory pathways that promote plaque formation and the progression of atherosclerosis. 

Vascular smooth muscle cells play a key role in maintaining vascular integrity, and their dysfunction contributes to the destabilization of plaques and the development of cardiovascular diseases.

This increases the risk of heart diseases and stroke, as inflammaging promotes acute vascular occlusion and myocardial infarction through plaque rupture and thrombosis, making inflammation a hidden but major contributor to cardiovascular mortality.

Cognitive function

Neuroinflammation, caused by elevated levels of inflammatory cytokines, can compromise the integrity of the blood-brain barrier. Age-related changes in the extracellular matrix can disrupt neural tissue structure, contributing to neurodegeneration and cognitive decline. This accelerates cognitive decline and elevates the risk of conditions like Alzheimer’s disease and dementia.

Muscles and bones

Inflammatory mediators hinder muscle protein synthesis, escalating muscle loss (sarcopenia) and contributing to frailty. Changes in growth factors, driven by inflammaging, impair muscle repair and bone remodeling, further exacerbating tissue deterioration. Simultaneously, inflammaging reduces bone density, increasing the likelihood of osteoporosis and fractures.

The root causes of inflammaging

The origins of inflammaging are multi-faceted, involving changes at cellular, systemic, and environmental levels. Age-related alterations in innate immune responses and immune systems contribute to chronic inflammation as the regulation of inflammatory processes becomes impaired. 

Aging also skews hematopoiesis toward increased production of myeloid cells, which impacts the immune response and promotes inflammaging. Additionally, stem cells play a crucial role in maintaining immune system health, and dysfunction or aging of these stem cells can further drive immune dysregulation and inflammaging. Here are some of the primary drivers:

  1. Cellular senescence and oxidative stress

Cell senescence, often referred to as “zombie cells,” refers to cells that cease dividing yet remain metabolically active. Cell senescence is characterized by cell cycle arrest and a persistent DNA damage response, both of which sustain the pro-inflammatory state of these cells. These senescent cells release inflammatory molecules collectively known as the senescence-associated secretory phenotype (SASP), perpetuating chronic inflammation.

  1. Gut microbiome dysregulation

Age-related changes in gut microbiota can compromise the gut barrier (leading to a “leaky gut”), allowing microbial byproducts to enter the bloodstream and fuel inflammation.

Microbial byproducts, including pathogen-associated molecular patterns (PAMPs), can activate immune receptors and fuel systemic inflammation.

  1. Lifestyle and environmental factors

Modern living exacerbates inflammaging:

  • Diet: Consuming processed and high-sugar foods increases oxidative stress, which in turn leads to cellular and molecular damage, ultimately driving chronic inflammation.
  • Physical inactivity: A sedentary lifestyle correlates with increased inflammatory markers.
  • Stress: Persistent stress elevates cortisol levels, exacerbating inflammatory pathways.
  • Poor sleep: Sleep disturbances disrupt immune regulation, amplifying inflammation.

The role of cell death in inflammaging

Cell death is a fundamental process in the human body, playing a pivotal role in the development and progression of inflammaging, a state of chronic inflammation that accelerates the aging process. As we age, the balance between healthy cell turnover and the accumulation of damaged or dysfunctional cells becomes disrupted, contributing to the onset of age-associated diseases and chronic conditions.

How does programmed cell death contribute to chronic inflammation?

Programmed cell death, such as apoptosis, is essential for removing cells that are damaged, no longer needed, or potentially harmful to the organism. However, when cells die, they can release molecules known as damage-associated molecular patterns (DAMPs). 

These DAMPs are recognized by pattern recognition receptors (PRRs) on immune cells, triggering immune responses that include the production of inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor (TNF). This process recruits additional immune cells, such as T cells and macrophages, to the site of cell death, amplifying the inflammatory response.

Over time, repeated or excessive activation of these immune responses can lead to chronic inflammation. The persistent presence of inflammatory mediators and inflammatory cells in tissues creates a cycle of ongoing tissue damage and repair, which is a hallmark of inflammaging. 

This chronic inflammatory environment not only impairs immune system function but also increases the risk of developing age-related chronic diseases, including cardiovascular disease, rheumatoid arthritis, and chronic kidney disease.

Apoptosis, necroptosis, and their impact on aging tissues

Different forms of cell death have distinct effects on aging tissues. Apoptosis, often referred to as “programmed cell death,” is a tightly regulated process that helps maintain tissue health by eliminating cells that are damaged or have reached the end of their functional lifespan. 

While apoptosis is generally non-inflammatory, excessive or dysregulated apoptosis can deplete essential cellular components, weaken tissue integrity, and contribute to the progression of aging-related diseases.

Necroptosis, on the other hand, is a form of programmed necrosis that is inherently pro-inflammatory. When necroptosis occurs, it leads to the release of cellular contents that act as inflammatory factors, further stimulating the immune system and promoting the production of inflammatory cytokines. This can exacerbate systemic inflammation and accelerate the development of age-associated diseases such as coronary artery disease and cognitive decline.

The interplay between apoptosis, necroptosis, and other forms of cell death is critical for maintaining tissue homeostasis. An imbalance, whether due to increased cell death or impaired clearance of dead cells,  can drive the accumulation of senescent cells and the activation of the senescence-associated secretory phenotype (SASP), further fueling chronic inflammation and the aging process.

The immune system plays a central role in maintaining this balance. Immune cells, including dendritic cells, T cells, and B cells, are responsible for recognizing and clearing dead or dying cells. When this process is compromised, as often occurs with aging, the resulting buildup of cellular debris and inflammatory molecules can perpetuate systemic inflammation and increase the risk of adverse health outcomes.

By targeting the pathways that regulate cell death, immune responses, and inflammatory mediators, scientists hope to develop new strategies for promoting healthy aging and reducing the burden of age-related chronic diseases.

Strategies to manage inflammaging

The science doesn’t just illuminate the problem; it also provides avenues for mitigating inflammaging through lifestyle changes and emerging interventions. Exercise, for example, acts as a natural anti-inflammatory agent, helping to reduce chronic inflammation associated with the aging process. Additionally, interventions that target energy metabolism, such as those that improve the balance between glycolysis and oxidative phosphorylation, can help reduce inflammaging and support healthier aging.

  1. Anti-inflammatory nutrition

Your diet is one of the most powerful tools for lowering chronic inflammation:

  • Prioritize the Mediterranean diet, rich in fruits, vegetables, nuts, olive oil, and fish. Its anti-inflammatory properties combat oxidative stress and inflammation. Anti-inflammatory diets can also help reduce insulin resistance, a key contributor to inflammaging and metabolic dysfunction.
  • Incorporate omega-3 fatty acids from sources like salmon and flaxseeds, which suppress the production of inflammatory cytokines.
  • Include antioxidant-rich foods like turmeric (curcumin), green tea, and berries for their potent anti-inflammatory polyphenols.
  1. Regular exercise

Physical activity is medicine for inflammaging. Regular exercise has a positive influence on the function and abundance of circulating cells, which play a crucial role in regulating inflammation. 

Studies show that aerobic and resistance exercise reduces levels of CRP and IL-6 while enhancing immune function. Aim for at least 150 minutes of moderate activity per week.

  1. Stress reduction and sleep hygiene
  • Engage in stress management techniques, such as meditation, yoga, or deep-breathing exercises, to lower cortisol and inflammatory markers.
  • Ensure 7–9 hours of high-quality sleep nightly. Address issues like sleep apnea, which are associated with increased inflammation.

Emerging therapies for inflammaging

Beyond lifestyle changes, groundbreaking therapies are being developed to slow or even reverse inflammaging at its root. Many of these emerging therapies are being designed to prevent or treat chronic disease, as persistent, low-grade inflammation is closely linked to the onset and progression of conditions such as cardiovascular disease, diabetes, and cancer.

  1. Senolytics

Senolytic drugs, such as Dasatinib and Quercetin, target and eliminate senescent cells, thereby reducing SASP-mediated inflammation. While still in early testing, they are a promising frontier in combating inflammaging.

  1. Microbiome-targeted treatments

Probiotics and prebiotics promote gut health and reduce systemic inflammation. Advanced options, such as fecal microbiota transplantation (FMT), are being explored to rejuvenate aging microbiomes.

  1. Nutritional supplements

Key supplements that show promise include:

  • Curcumin: Curbs inflammation by inhibiting nuclear factor-kappa B (NF-kB) signaling.
  • Vitamin D: Modulates immune responses, with deficiencies linked to higher inflammatory markers.
  • Zinc and omega-3s: Both support cellular repair and lower systemic inflammation.
  • Antioxidant-rich foods or supplements: These compounds help neutralize reactive oxygen species (ROS), which contribute to inflammaging by promoting cellular senescence, mitochondrial dysfunction, and activation of inflammatory pathways.

Bottom line

Inflammaging is not an inevitable, irreversible process. If left unchecked, inflammaging can lead to accelerated aging and increase the risk of age-related diseases. 

By understanding its mechanisms and taking proactive steps, including dietary modifications, exercise, stress management, and emerging therapies, you can significantly enhance both the quality and length of your life.

Are you ready to combat inflammaging? Start by evaluating your lifestyle and making intentional choices today. Small, consistent actions can yield profound anti-aging results.

Frequently asked questions (FAQs)

  1. At what age does inflammaging typically begin?

Inflammaging can start as early as the 20s to 30s, but becomes more pronounced after age 50. The process is gradual and varies significantly among individuals, depending on their genetics and lifestyle factors.

  1. Can inflammaging be completely reversed?

While some inflammatory damage may be permanent, research indicates that lifestyle interventions can significantly reduce inflammatory markers and slow the process of inflammaging. The earlier you start, the more effective the interventions.

  1. What blood tests can detect inflammaging?

Common inflammatory markers include C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Your doctor can order these tests along with a complete metabolic panel to assess inflammation levels.

  1. How long does it take to see results from anti-inflammaging interventions?

Some inflammatory markers can improve within 2-4 weeks of dietary changes or increased exercise, but significant anti-aging benefits typically require 3-6 months of consistent lifestyle modifications.

  1. Are supplements necessary to fight inflammaging?

While a well-balanced diet should provide most nutrients, certain supplements like omega-3s, vitamin D, and curcumin may provide additional anti-inflammatory benefits, especially if you have deficiencies or higher inflammation levels.

  1. How does inflammaging affect immune cell populations?

Inflammaging leads to an accumulation of memory T cells, effector memory T cells, and CD8 T cells in aged tissues. These changes are associated with T cell senescence, which impairs immune function and contributes to chronic inflammation and immune dysfunction as we age.

References

  1. Monti, D., Ostan, R., Borelli, V., Castellani, G., & Franceschi, C. (2017). Inflammaging and human longevity in the omics era. Mechanisms of Ageing and Development, 165, 129-138.
  2. Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018). Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology, 14, 576-590.
  3. Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023). Inflammation and aging: signaling pathways and intervention therapies. Signal Transduction and Targeted Therapy, 8, 239.
  4. Dugan, B., Conway, J., & Duggal, N.A. (2023). Inflammaging as a target for healthy ageing. Age and Ageing, 52(2), afac328.

Share
4 subscribe
Subscribe

RELATED CONTENT

Understanding heart age and its role in cardiovascular health
Heart Age and Cardiovascular Health: How to Stay Younger, Longer
More
How to age gracefully tips and supplements for vitality
How to Age Gracefully: Tips and Supplements for Vitality 
More
Dose coffee age you what science says about your daily brew
Does Coffee Age You? What Science Really Says About Your Daily Brew
More
How old is old exploring the perspectives on aging and subjective definitions of old age
How Old Is Old? Exploring the Perspectives on Aging and Subjective Definitions of Old Age
More

Longevity, Delivered to Your Inbox

Subscribe for curated research updates, practical tips, and the latest anti-aging breakthroughs

Subscription Form

Colton

Colton Qiu, PhD

Editor-in-Chief, Scientific Research

Colton is a regenerative medicine scientist with a focus on transfusion science, stem cell engineering, and platelet-based therapies. He earned his PhD in Medicine from Kyoto University’s Center for iPS Cell Research and Application (CiRA), the pioneering institute behind induced pluripotent stem cell (iPSC) technology. His research centered on improving the biomanufacturing process and long-term preservation of iPSC-derived platelets, advancing their applications in both transfusion medicine and next-generation PRP (platelet-rich plasma) therapies for tissue regeneration.

Beyond the lab, Colton is the co-founder and former president of the Japan–Taiwan Biotechnology Association (JTBA), where he played a pivotal role in establishing high-impact collaborations between academia, industry, and government to foster regenerative medicine innovation across Asia. He completed his doctoral training with the support of the Japan–Taiwan Exchange Association Scholarship, awarded for his outstanding contributions to cross-cultural scientific advancement.

Since completing his PhD, Colton has turned his focus toward the future of personalized healthcare. He firmly believes that science-backed strategies to delay aging and enhance healthspan already exist—but they must be tailored to each individual. Rejecting the idea of a “one-size-fits-all” solution, he advocates for making personalized longevity planning both scientifically rigorous and economically accessible. His mission is to help more people design evidence-based, customized pathways to healthier, longer lives.

Right down 2
Tristan

Tristan Yeung, MD

Editor-in-Chief, Medical Research

Tristan brings a distinctive perspective to longevity research through his integration of clinical medicine, translational research, and biomedical innovation. His MD from Harvard Medical School, combined with extensive engagement with Harvard Innovation Lab and HMS Makerspace, reflects his commitment to transforming scientific discoveries into practical interventions that can extend healthy human lifespan. His internal medicine internship at California Pacific Medical Center provides him with frontline clinical experience in treating age-related diseases, giving him intimate knowledge of how aging manifests in real patients and what interventions might have the greatest impact on healthspan extension.

Tristan’s translational research at Stanford’s Department of Radiology and Canary Center, where he implemented novel microRNA-encapsulated nanoparticle drug delivery systems for localized cancer treatment, demonstrates his expertise in cutting-edge therapeutic delivery mechanisms increasingly relevant to anti-aging interventions. His bioengineering background from Stanford University, where he developed a vitamin-eluting subdermal implantable rod for nutritional deficiencies as a Terman Engineering Scholar, showcases his innovative approach to sustained therapeutic delivery – a critical consideration for longevity interventions that must work over extended timeframes. Tristan’s unique combination of clinical training, research expertise, and entrepreneurial vision enables him to identify which longevity interventions hold promise for extending not just lifespan, but healthspan.

Right down 2
Jean cruz

Jean Cruz-Hernandez, PhD

Scientific Advisor

Jean Cruz (JC) combines deep scientific rigor with strategic vision as Global Managing Partner of AGMI, bringing a rare blend of bench science expertise and commercial acumen to longevity research analysis. His PhD in Biomedical Engineering from Cornell University, coupled with a postdoctoral fellowship and junior faculty position at Massachusetts General Hospital and Harvard Medical School, provides him with the technical depth needed to evaluate complex longevity interventions with scientific precision. JC’s pioneering work in neurodegenerative diagnostic and imaging platforms during his academic career gives him unique insight into one of aging’s most devastating aspects – cognitive decline, while his research that produced several US patents, over $5 million in sponsored grants, and publications in Nature demonstrates his ability to identify breakthrough approaches that could revolutionize how we understand aging processes. His specialized research initiatives focused on understanding aging-related neurological decline and developing therapeutic interventions position him at the forefront of one of longevity science’s most critical frontiers.

His extensive experience at McKinsey & Company, where he led strategic transformations for Fortune 500 pharma companies and conducted due diligence across oncology, neuroscience, and rare-disease portfolios, equips him to navigate the complex landscape of longevity research with both scientific rigor and commercial insight. JC’s work positions him to identify which approaches have genuine therapeutic potential versus those destined for clinical failure. JC brings unparalleled expertise in translating cutting-edge aging research into practical strategies that can extend healthy human aging.

Right down 2
Harvey

Yen-Po (Harvey) Chin, MD, PhD

Medical Advisor and Strategy Lead

Harvey brings a unique convergence of clinical medicine, bioinformatics, and advanced analytics to the pursuit of longevity science, combining deep scientific training with strategic vision to advance anti-aging research. His medical training from National Yang Ming Chiao Tung University and his PhD in Biomedical Informatics from Taipei Medical University, coupled with his postdoctoral Master of Biomedical Informatics from Harvard Medical School, positions him uniquely at the intersection where cutting-edge longevity research meets computational analysis and practical implementation. As a physician turned entrepreneur, Harvey understands both the clinical realities of aging-related diseases and the technological possibilities for intervention, giving him rare insight into how breakthrough biomedical innovations can translate from laboratory discoveries to meaningful patient outcomes.

As a Forbes 30 Under 30 honoree and Harvard Healthtech Innovation Fellow, Harvey has consistently identified and championed emerging technologies before they reach mainstream adoption, a skill directly applicable to the rapidly evolving field of longevity research. His experience as Executive Chairman of AGMI Group, where he has orchestrated over $1.5 billion in potential value through strategic partnerships in biopharma and advanced technology enterprises, demonstrates his ability to discern which medical interventions hold genuine therapeutic promise versus those destined for clinical failure. His frequent speaking engagements at Harvard, MIT, BIO Asia Conference, and Academia Sinica position him to stay at the forefront of longevity research developments as they emerge from the world’s leading institutions, while his commitment to developing the next generation of leaders through the AAC Talent Hub reflects his dedication to ensuring breakthrough anti-aging discoveries benefit future generations.

Right down 2

Longevity, Delivered to Your Inbox

Subscribe for curated research updates, practical tips, and the latest anti-aging breakthroughs

Subscription Form